William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Silence Therapeutics closes $201M public offering of ADSs
-
Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
KKR prices secondary offering of 5 million BridgeBio shares
-
BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base
-
KKR to sell 5 million BridgeBio shares in secondary offering
-
BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder
-
Savers Value Village closes 23M share secondary offering
-
Savers Value Village, Inc. Announces Closing of Upsized Secondary Public Offering of Common Stock and Concurrent Share Repurchase
-
Guggenheim Securities Hires Blake Jones to Expand Global Services Investment Banking Coverage
-
William Blair Downgrades Accelerant Holdings (ARX) to Market Perform
-
Form 13F-HR WILLIAM BLAIR INVESTMENT For: Jun 30
-
William Blair Downgrades Cardiff Oncology (CRDF) to Market Perform
-
Silence Therapeutics prices $175 million public offering at $13.50 per ADS
-
Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
-
Savers Value Village prices $205M secondary stock offering
-
Savers Value Village, Inc. Announces Pricing of Upsized Secondary Public Offering of Common Stock and Concurrent Share Repurchase
-
Form SCHEDULE 13G Revolve Group, Inc. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G/A Twist Bioscience Corp Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G/A i3 Verticals, Inc. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
William Blair Downgrades On Holding AG (ONON) to Market Perform
-
Form 13F-HR BLAIR WILLIAM & CO/IL For: Jun 30
-
William Blair Assumes Applied Materials (AMAT) at Market Perform
-
On Holding Q2 seen holding strong as spending data counters July search slowdown
-
Silence Therapeutics launches $150 million ADS public offering
-
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
-
William Blair Downgrades Tenax Therapeutics (TENX) to Market Perform
-
Lyntris launches IPO at $19-$22 per share on NYSE
-
Lyntris Inc. Announces Launch of its Initial Public Offering
-
William Blair Starts Standard Nuclear (STDN) at Outperform
-
William Blair cites tight labor market in staffing stock outlook
-
KKR closes equity investment in Crowe Advisory LLC
